Possibilities of dried blood spots as a matrix in therapeutic drug monitoring of antiepileptic drugs in children
Author: Linder, Camilla
Date: 2019-06-14
Location: C1:87, Karolinska University Hospital, Huddinge
Time: 09.00
Department: Inst för laboratoriemedicin / Dept of Laboratory Medicine
View/ Open:
Thesis (1.093Mb)
Abstract
For children with epilepsy, therapeutic drug monitoring (TDM) of antiepileptic drugs (AEDs) is essential for treatment. TDM monitoring requires two visits to a health care unit, first for collection of the blood sample before the morning dose and a few days later the family will travel once again to see the pediatrician. For this patient group, blood from a fingerprick, collected on a filter paper at home and sent by mail to the laboratory as a dried blood spot (DBS), could be beneficial and facilitate everyday life.
The aim of this thesis has been to investigate whether it is possible to use DBS as a matrix for TDM of common AEDs interchangeably with plasma. A second aim was to study the DBS self-sampling process, to see if guardians of children with epilepsy were able to collect DBS samples with sufficient quality and find what factors influenced a successful collection. Precise and robust liquid chromatography tandem mass spectrometry (LC-MS/MS) methods, using DBS as a matrix, were developed and validated for four major AEDs. The methods met acceptance criteria from the European Medicine’s Agency (Paper I and III). Patient samples were collected from children treated with carbamazepine (CBZ), lamotrigine (LTG), levetiracetam (LEV) and valproic acid (VPA) to perform bridging studies and compare DBS concentrations with plasma.
Results concluded that a factor was needed to convert DBS concentrations for CBZ and VPA, to estimated plasma concentrations (Paper II). In the clinical evaluation, only 4 out of 190 comparisons of DBS and plasma concentrations resulted in different dose recommendations The DBS self-collection process was evaluated by comparing the quality of samples obtained from a group of pediatric nurses with a group of guardians to children with epilepsy. Results showed that guardians could collect acceptable quality DBS samples from their children (Paper IV). A mixed method study showed that most of the guardians (80%) found self-sampling at home desirable after a training session. Factors for successful self-sampling were; high motivation, prepared guardians, flexible education with support from a nurse, effective communication between the guardian and the child and that guardians were willing to take on the role as performers (PaperV).
The conclusion was that children with epilepsy and their guardians can use DBS as an alternative matrix for self-sampling, and that DBS concentrations of CBZ, LTG and VPA can be analyzed for TDM purposes. DBS for LEV can be collected for compliance queries or for patients where the alternative is no sample at all. These patients are monitored closely and in cases where DBS samples collected at home result in a concentration deviating from the expected or at risk of adverse effects, it is recommended to also collect a plasma sample. Guardians of children with epilepsy are interested in performing self-sampling and by being offered DBS self-collection at home these families can save time and have lower stress levels.
The aim of this thesis has been to investigate whether it is possible to use DBS as a matrix for TDM of common AEDs interchangeably with plasma. A second aim was to study the DBS self-sampling process, to see if guardians of children with epilepsy were able to collect DBS samples with sufficient quality and find what factors influenced a successful collection. Precise and robust liquid chromatography tandem mass spectrometry (LC-MS/MS) methods, using DBS as a matrix, were developed and validated for four major AEDs. The methods met acceptance criteria from the European Medicine’s Agency (Paper I and III). Patient samples were collected from children treated with carbamazepine (CBZ), lamotrigine (LTG), levetiracetam (LEV) and valproic acid (VPA) to perform bridging studies and compare DBS concentrations with plasma.
Results concluded that a factor was needed to convert DBS concentrations for CBZ and VPA, to estimated plasma concentrations (Paper II). In the clinical evaluation, only 4 out of 190 comparisons of DBS and plasma concentrations resulted in different dose recommendations The DBS self-collection process was evaluated by comparing the quality of samples obtained from a group of pediatric nurses with a group of guardians to children with epilepsy. Results showed that guardians could collect acceptable quality DBS samples from their children (Paper IV). A mixed method study showed that most of the guardians (80%) found self-sampling at home desirable after a training session. Factors for successful self-sampling were; high motivation, prepared guardians, flexible education with support from a nurse, effective communication between the guardian and the child and that guardians were willing to take on the role as performers (PaperV).
The conclusion was that children with epilepsy and their guardians can use DBS as an alternative matrix for self-sampling, and that DBS concentrations of CBZ, LTG and VPA can be analyzed for TDM purposes. DBS for LEV can be collected for compliance queries or for patients where the alternative is no sample at all. These patients are monitored closely and in cases where DBS samples collected at home result in a concentration deviating from the expected or at risk of adverse effects, it is recommended to also collect a plasma sample. Guardians of children with epilepsy are interested in performing self-sampling and by being offered DBS self-collection at home these families can save time and have lower stress levels.
List of papers:
I. Linder C, Andersson M, Wide K, Beck O, Pohanka A. A LC-MS/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS. Bioanalysis. 2015; 7(16): 2031-39.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Linder C, Wide K, Walander M, Beck O, Gustafsson LL, Pohanka A. Comparison between dried blood spot and plasma sampling for therapeutic drug monitoring of antiepileptic drugs in children with epilepsy: A step towards home sampling. Clin Biochem. 2016; 50: 412–8.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Linder C, Hansson A, Sadek S, Gustafsson LL, Pohanka A. Carbamazepine, lamotrigine, levetiracetam and valproic acid in dried blood spots with liquid chromatography tandem mass spectrometry; method development and validation. J Chromatogr B. 2018; 1072: 116–22.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Linder C, Neideman M, Wide K, von Euler M, Gustafsson LL, Pohanka A. Dried blood spot self-sampling by guardians of children with epilepsy is feasible: comparison with plasma for multiple antiepileptic drugs. Therapeutic Drug Monitoring. 2019; Feb 22.
Fulltext (DOI)
Pubmed
I. Linder C, Andersson M, Wide K, Beck O, Pohanka A. A LC-MS/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS. Bioanalysis. 2015; 7(16): 2031-39.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Linder C, Wide K, Walander M, Beck O, Gustafsson LL, Pohanka A. Comparison between dried blood spot and plasma sampling for therapeutic drug monitoring of antiepileptic drugs in children with epilepsy: A step towards home sampling. Clin Biochem. 2016; 50: 412–8.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Linder C, Hansson A, Sadek S, Gustafsson LL, Pohanka A. Carbamazepine, lamotrigine, levetiracetam and valproic acid in dried blood spots with liquid chromatography tandem mass spectrometry; method development and validation. J Chromatogr B. 2018; 1072: 116–22.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Linder C, Neideman M, Wide K, von Euler M, Gustafsson LL, Pohanka A. Dried blood spot self-sampling by guardians of children with epilepsy is feasible: comparison with plasma for multiple antiepileptic drugs. Therapeutic Drug Monitoring. 2019; Feb 22.
Fulltext (DOI)
Pubmed
Institution: Karolinska Institutet
Supervisor: Pohanka, Anton
Co-supervisor: Bastholm-Rahmner, Pia; Beck, Olof; Gustafsson, Lars
Issue date: 2019-05-21
Rights:
Publication year: 2019
ISBN: 978-91-7831-421-8
Statistics
Total Visits
Views | |
---|---|
Possibilities ... | 693 |
Possibilities ...(legacy) | 147 |
Total Visits Per Month
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | |
---|---|---|---|---|---|---|---|
Possibilities ... | 12 | 14 | 2 | 5 | 0 | 3 | 2 |
File Visits
Views | |
---|---|
Thesis_Camilla_Linder.pdf | 1239 |
Thesis_Camilla_Linder.pdf(legacy) | 66 |
Top country views
Views | |
---|---|
United States | 173 |
Sweden | 124 |
China | 83 |
Germany | 49 |
Australia | 42 |
United Kingdom | 34 |
Russia | 32 |
Ireland | 28 |
Denmark | 25 |
Poland | 21 |
Top cities views
Views | |
---|---|
Ashburn | 73 |
Sydney | 40 |
Hangzhou | 30 |
Dublin | 28 |
Stockholm | 23 |
Copenhagen | 20 |
Mountain View | 13 |
Huddinge | 10 |
Beijing | 8 |
Frankfurt am Main | 8 |